Enlivex Therapeutics
ENLV
ENLV
3 hedge funds and large institutions have $461K invested in Enlivex Therapeutics in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$47.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$33K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $428K | +$47.4K | +2,201 | +12% |
|
|
2
UBS Group
Zurich,
Switzerland
| $33K | +$33K | +1,540 | New |
|